Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing, and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer.
Rigel has 3 FDA approved products:
-TAVALISSE® (fostamatinib disodium hexahydrate) tablets www.TAVALISSEhcp.com
-GAVRETO® (pralsetinib) capsules www.GAVRETO-hcp.com
-REZLIDHIA® (olutasidenib) capsules. Visit www.REZLIDHIAhcp.com to see the Full Prescribing Information, including Boxed WARNING